Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,272	7,601	3,129	3,015	1,945	1,754
Market Cap Growth	-51.51%	142.94%	3.77%	55.05%	10.89%	-7.08%
Enterprise Value	3,521	7,793	3,255	3,130	2,127	1,985
Last Close Price	7.89	18.33	7.51	7.27	4.72	4.33
PE Ratio	-	-	-	334.55	-	-
Forward PE	-	18.69	18.69	18.69	18.69	18.69
PS Ratio	15.14	43.63	13.26	10.97	6.07	6.51
PB Ratio	8.09	18.47	6.04	5.19	3.43	2.93
P/TBV Ratio	11.50	22.66	7.47	6.83	4.83	4.09
P/OCF Ratio	298.46	-	268.82	119.56	82.56	-
EV/Sales Ratio	16.29	44.73	13.80	11.39	6.64	7.37
EV/EBITDA Ratio	164.00	-	205.51	235.43	451.32	-
EV/FCF Ratio	-459.66	-	-	-	-	-
Debt / Equity Ratio	0.72	0.67	0.36	0.38	0.31	0.37
Debt / EBITDA Ratio	13.55	-	11.75	16.80	37.71	-
Asset Turnover	0.27	0.22	0.28	0.31	0.36	0.29
Inventory Turnover	1.28	1.09	1.18	1.57	1.62	1.31
Quick Ratio	0.44	0.41	0.43	0.58	1.01	1.06
Current Ratio	0.86	0.88	0.97	0.79	1.53	1.53
Return on Equity (ROE)	-14.23%	-22.87%	-13.10%	-1.48%	-7.00%	-12.53%
Return on Assets (ROA)	-2.36%	-5.65%	-2.69%	-3.13%	-3.52%	-4.06%
Return on Invested Capital (ROIC)	-4.78%	-10.92%	-5.54%	-6.67%	-7.15%	-8.21%
Return on Capital Employed (ROCE)	-5.20%	-11.80%	-5.60%	-7.50%	-6.60%	-7.80%
Earnings Yield	-1.31%	-1.03%	-1.62%	0.30%	-1.04%	-3.04%
FCF Yield	-0.23%	-0.86%	-1.20%	-0.26%	-0.42%	-3.54%
Payout Ratio	-	-	-	123.52%	-	-
Buyback Yield / Dilution	2.48%	2.53%	6.16%	-10.85%	0.91%	0.17%
Total Shareholder Return	2.48%	2.53%	6.16%	-10.85%	0.91%	0.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.